Risk Paradigm Group’s Biogen BIIB Stock Holding History

Risk Paradigm Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-630	Closed	-$173K	–	105
2018 Q1	$173K	Hold	630	–	–	0.22%	88
2017 Q4	$201K	Hold	630	–	–	0.22%	96
2017 Q3	$197K	Sell	630 -80	-11%	-$23.7K	0.24%	85
2017 Q2	$193K	Buy	710 +58	+9%	+$15.3K	0.23%	96
2017 Q1	$178K	Sell	652 -30	-4%	-$8.48K	0.2%	88
2016 Q4	$193K	Sell	682 -185	-21%	-$54.8K	0.21%	95
2016 Q3	$271K	Hold	867	–	–	0.2%	93
2016 Q2	$210K	Buy	867 +65	+8%	+$17.1K	0.28%	83
2016 Q1	$209K	Buy	802 +285	+55%	+$75.3K	0.27%	64
2015 Q4	$158K	Buy	517 +495	+2,250%	+$142K	0.19%	74
2015 Q3	$6.42K	Hold	22	–	–	0.01%	249
2015 Q2	$8.89K	Hold	22	–	–	0.01%	225
2015 Q1	$9.29K	Buy	+22	New	+$8.67K	0.01%	225

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Risk Paradigm Group's BIIB Position: Q2 2018 in Review

Risk Paradigm Group sold out of Biogen (BIIB) in Q2 2018, closing a stake of 630 shares — an estimated $173K sold.

Risk Paradigm Group first reported a position in BIIB in Q1 2015 and held it in 13 quarters. The position peaked at $271K in Q3 2016. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

Risk Paradigm Group reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
Risk Paradigm Group sold 630 Biogen shares in Q2 2018, an estimated $173K.
Risk Paradigm Group first reported a position in Biogen in Q1 2015 and held it in 13 quarters.
Risk Paradigm Group's Biogen position peaked at $271K in Q3 2016.
1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Risk Paradigm Group's 13F filing for Q2 2018, filed 10 Aug 2018.